Janet Woodcock (Bill Clark/CQ Roll Call via AP Images)
HHS extends Aduhelm investigation into the accelerated approval pathway, wading into a brewing controversy
The government investigation into how the FDA approved Aduhelm appears to point well beyond the agency’s ties with Biogen in the leadup to its approval …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
